Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.
|Slideshows|September 11, 2020
6 Sleep Myths: Experts Weigh In
Author(s)Chris Aiken, MD
Ten sleep specialists assessed widely accepted beliefs and here's what they found.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
2
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
3
Can Digital Memory Tests Detect Tau-Related Cognitive Change Before Alzheimer Disease?
4
Preventing Schizophrenia Relapse in Women: What You Need to Know
5